6 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 3 |
Follow Cocrystal Pharma, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus CDI-988, Placebo, Snow Mountain Virus - Norovirus | Phase 1 / Phase 2 | Completed | Cocrystal Pharma, Inc. | 32 | 2026-02-23 | 2026-10-22 |
| Influenza Viral Challenge Study of CC-42344 in Healthy Participants CC-42344, Placebo - Influenza A | Phase 2 | Completed | Cocrystal Pharma, Inc. | 78 | 2023-11-25 | 2025-08-05 |
| CDI-988 Safety Study in Healthy Participants CDI-988, Placebo - Healthy Volunteers | Phase 1 | Completed | Cocrystal Pharma, Inc. | 94 | 2023-09-27 | 2026-08-19 |
| CC-42344 Safety Study in Healthy Participants CC-42344, Placebo - Influenza A | Phase 1 | Completed | Cocrystal Pharma, Inc. | 80 | 2022-02-11 | 2026-02-19 |
| Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) CDI-31244, SOF/VEL - Chronic Hepatitis C | Phase 2 | Completed | Cocrystal Pharma, Inc. | 12 | 2018-06-26 | 2021-04-28 |
| A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects CDI-31244, Placebo - Hepatitis C | Phase 1 | Completed | Cocrystal Pharma, Inc. | 76 | 2016-04-01 | 2021-04-20 |
Coronavirus Infections (1) · Hepatitis C (1) · Hepatitis C, Chronic (1)
Exercise (1) · sofosbuvir-velpatasvir drug combination (1)
Australia (2) · United States (2) · Canada (1) · United Kingdom (1)
Christopher Argent, MD (1) · Joel Chua, MD (1) · Judy Pattassery (1) · Nadine Rouphael, MD (1) · Sam Salman, MD (1) · Victoria Parker, MMBS (1)